APCER Pharma Announces That LPC Pharma Group To Outsource Pharmacovigilance/Drug Safety To APCER
Main Category: Pharmacy / PharmacistAlso Included In: Pharma Industry / Biotech Industry
Article Date: 09 Feb 2010 - 0:00 PDT
| Patient / Public: | ![]() |
1 (1 votes) |
| Healthcare Prof: | ![]() |
APCER Pharma announced that LPC Pharma Group is outsourcing its http://www.pharmacovigilance/drug safety operations to APCER.
APCER is a leading global provider of comprehensive drug safety, regulatory services and risk management programs for pharmaceutical, biotechnology, medical device and consumer products companies.
LPC, based in Luton, specialises in the supply of branded and generic medicines across the UK. It owns the intellectual property for over 150 licences enabling supply of own label and several brands such as Uvistat sun cream, Dalivit Multivitamin Drops and Hill's Balsam for Chesty and Dry Cough.
LPC Director Satnam Butter said, "APCER uses best in class, validated processes and technology. Their staff have excellent training and qualifications. Outsourcing our pharmacovigilance operations to the experts at APCER allows LPC to focus our resources on our areas of expertise."
Michael Reynolds, APCER's Head of Sales and Marketing for Europe, Asia and Africa, said, "We're delighted to be working with LPC. Maintaining the system is one of the most expensive, time-consuming burdens facing a pharmaceutical company. APCER is 100% committed to our customers' successes. We maintain continuous contact through visits and regular updates, which enables smooth and efficient implementations. Our team becomes an extension of every client's operation."
Pharmaceutical companies must invest more resources and budget to manage their compliance with pharmacovigilance regulatory requirements within ICH regions. APCER's pharmacovigilance/drug safety experts provide a complete range of services based on a fully electronic platform which is compliant with ICH-E2B (EU) and 21 CFR part 11 (US-FDA) regulatory requirements.
Source
APCER Pharma
Visit our pharmacy / pharmacist section for the latest news on this subject.
MLA
16 Feb. 2012. <http://www.medicalnewstoday.com/releases/178503.php>
APA
http://www.medicalnewstoday.com/releases/178503.php.
Please note: If no author information is provided, the source is cited instead.
|
Rate this article: (Hover over the stars then click to rate) |
Patient / Public: |
or |
Health Professional: |
Add Your Opinion
Please note that we publish your name, but we do not publish your email address. It is only used to let you know when your message is published. We do not use it for any other purpose. Please see our privacy policy for more information.
If you write about specific medications or operations, please do not name health care professionals by name.
All opinions are moderated before being included (to stop spam)
Contact Our News Editors
For any corrections of factual information, or to contact the editors please use our feedback form.
![]()
Please send any medical news or health news press releases to:
Note: Any medical information published on this website is not intended as a substitute for informed medical advice and you should not take any action before consulting with a health care professional. For more information, please read our terms and conditions.




